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Background: The prevalence of undiagnosed asthma in the general population and the clinical and
demographic characteristics of these patients compared with those with diagnosed asthma are unclear.
Methods: The North West Adelaide Health Survey (NWAHS) is a population household interview survey
of adults (age .18 years) in the north western suburbs of Adelaide, South Australia (regional population
0.6 million). Data obtained were weighted to the closest census data to provide population representative
estimates. Positive answers to: ‘‘Have you ever had asthma?’’; ‘‘Has it been confirmed by a doctor?’’; ’’Do
you still have asthma?’’ determined current physician diagnosed asthma. A positive bronchodilator
response on spirometric testing according to ATS criteria without a physician’s diagnosis determined
undiagnosed asthma. Other measures included the SF-12 health survey questionnaire, the Selim index of
severity of chronic lung disease, skin allergy tests, and demographic data.
Results: Of the 3422 individuals interviewed, 2523 (74%) agreed to participate in the clinical assessment.
Of these, 292 (11.6%) had asthma, 236 (9.3%) with a doctor’s diagnosis of asthma and 56 (2.3%) with
undiagnosed asthma defined on spirometric criteria; thus, 19.2% of the total asthma group were
undiagnosed. Those undiagnosed were more likely (p,0.05) to be .40 years old, on government
benefits, with an income ,AUD$40 000. Symptom frequency was similar in the two asthma groups, but
mean spirometric values were lower in the undiagnosed group (p,0.05) while positive skin allergy tests
were more common in the diagnosed group (p,0.05). SF-12 component summary scores were
significantly lower in both asthma groups than in the non-asthma population. Undiagnosed asthma was
frequent in men and in those aged .65 years. Health service use over the previous year was similar for
both asthma groups.
Conclusion: Undiagnosed asthma is common among the Australian population, with a similar clinical
spectrum to those with diagnosed asthma.
U
ncontrolled asthma can be associated with an increased
decline in forced expiratory volume in 1 second (FEV1)
that may result in chronic airflow limitation.1 There is
evidence that early intervention in asthma, particularly with
inhaled corticosteroids, has a substantial impact on later
morbidity.2 3 Identifying people with undiagnosed asthma
has the potential to reduce the impairment in health and
functional status associated with this condition.
The prevalence of undiagnosed airflow obstruction has
been described in several European countries4–9 and the US,9
and estimates have varied widely from 3.2% to 11.8%. These
studies have been limited to older populations, few have
separated chronic obstructive pulmonary disease (COPD)
from asthma, and there is limited information on the health
and functional impact of undiagnosed asthma. There have
been marked differences in the severity of disease found in
the undiagnosed groups between various studies.4 5 8 9
Belousova et al reported that 3% of an adult Australian
population aged 30–50 years had asymptomatic airway
hyperresponsiveness, assessed by a positive histamine chal-
lenge test or a positive bronchodilator response.10 They did
not report on the concurrent clinical impact on these people.
The clinical importance of undiagnosed asthma remains
uncertain, and therefore the role of screening programmes
remains controversial.9 11
We have examined this issue using data from The North
West Adelaide Health Study (NWAHS), a representative
biomedical population study of people aged 18 years or older
living in the north west area of Adelaide, South Australia. In
this analysis we describe the prevalence of asthma and
compare the demographic characteristics, lung function,
symptoms, quality of life status, and health service use of




The North West Adelaide Health Study (NWAHS) is a
representative biomedical population study of people aged
18 years or older living in the north western suburbs of
Adelaide, South Australia (regional population 0.6 million).
This area was considered a priority study area because of
previous self-report evidence concerning the high levels of
chronic disease and risk factors in the region compared with
the rest of the state.12 Over 56% of adults in the region have
two or more cardiovascular risk factors, including 40% with
four or more such risk factors.13 In addition, measures of
social disadvantage have identified parts of this region with
greater relative social disadvantage than many other areas of
South Australia.14 The aims of the study were to provide
estimates of diabetes, asthma, and COPD and associated risk
factors and quality of life for the northern and western
regions of Adelaide. A further aim of the study was to provide
an estimation of previously undiagnosed rates of these
diseases and a demographic description and risk factor
profile of the groups of concern.
Study design
Households selected at random from the electronic white
pages telephone directory were interviewed by telephone and
recruited to a clinical assessment. In each selected household
the person aged 18 years or older who was last to have a
birthday was asked to participate. The study was performed
from February to December 2000. Telephone interviews by
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trained health interviewers investigated self-reported health
status, mental health, smoking status, and demographic
variables. Of the 3422 individuals interviewed, 2523 (74%)
agreed to participate in the clinical assessment. A ques-
tionnaire was then sent to each participant for self-comple-
tion. This comprised items on the frequency of alcohol
consumption, exercise patterns, more detailed demographic
information, health service use, the SF-36 questionnaire, and
the Selim Index of Chronic Lung Disease (CLD).
The Selim CLD Index is made up of six items that form
three subscales: frequency and intensity of dyspnoea;
frequency and intensity of wheezing; frequency of coughing
and amount of sputum production over the past 3 months.15
The CLD Index has been validated in US and Australian
population studies.15 16 It has shown a high level of agreement
with clinical data, including peak flow measurements.15 The
index is scored out of 100, and the result is categorised into
mild ((43), moderate (44–62), and severe (.62) levels of
severity.15 These categories have demonstrated discriminative
value between different levels of chronic lung disease that
impact on quality of life across physical and mental health
scales.16
Medical assessment comprised spirometric tests, blood
pressure measurement, height, weight, waist and hip
measurements, fasting blood, and allergy skin tests to rye
grass, cat, house dust mite, Alternaria, feather, and cockroach.
Spirometric tests were conducted at the two hospitals
according to American Thoracic Society criteria.17
To determine doctor diagnosed asthma, participants were
asked if they had ever had asthma, whether a doctor
confirmed their asthma, and if they still had asthma.
Individuals with current asthma were defined as those who
reported having been told by a doctor they had asthma or
those who had a 15% increase in forced expiratory volume in
1 second (FEV1) following a bronchodilator, or those who
had a 12% increase in FEV1 following a bronchodilator if the
absolute difference in FEV1 was greater than 200 ml.
Undiagnosed asthma was defined by a positive acute
bronchodilator response on spirometric testing in those
who did not report a doctor’s diagnosis of asthma. No
measurements of non-specific airway hyperresponsiveness
were made.
Statistical analysis
Data were analysed using SPSS version 10.0. Differences in
proportions were assessed for significance using x2 tests and
Mantel-Haenszel methods for analysis of 2 6 k tables.
Standardised scores for the SF-36 questionnaire were
calculated after the method of Garrett at al.18 Standard scores
were calculated for each health summary scale by dividing
the difference in the quality of life score by the standard
deviation of the population summary scale. The mean of the
general state population was set at zero for each summary
score, allowing comparisons to be made with each of the
asthma groups in terms of standard deviations. Kazis et al19
discuss the techniques for interpreting the differences
between groups in standard scores. An effect size of 0.2 is
described as small or mild, 0.4 as moderate, and >0.8 as
large.
Approval for the NWAHS study was obtained from the
institutional ethics committees at the two hospitals involved.
RESULTS
Of the 2523 adult participants, 292 (11.6%) had asthma. Of
these, 236 (9.3%) had a self-reported doctor’s diagnosis of
asthma and 56 (2.3%, 95% CI 1.7 to 2.9) were unaware of the
diagnosis and were defined as having asthma on spirometric
criteria. Thus, 19.2% of the total asthma group had
undiagnosed asthma. Table 1 shows the demographic
characteristics of the groups with asthma compared with
those without asthma. Bivariate analyses showed that
subjects with previously undiagnosed asthma were signifi-
cantly more likely than those with self-reported diagnosed
asthma to be aged over 40 years, to be born outside Australia,
to be retired or undertaking home duties, to be receiving a
social security pension, and to have an annual income of
,AUD$40 000 (table 2). Those with diagnosed asthma were
significantly more likely to be atopic with positive skin
reactions to one or more of rye grass, house dust mite, and
Alternaria allergens. A multiple logistic regression model
showed that undiagnosed asthma was independently asso-
ciated with being male (OR 2.1, 95% CI 1.2 to 3.6), age
.40 years (OR 2.4, 95% CI 1.1 to 5.5), income ,AUD$40 000
(OR 3.9, 95% CI 1.7 to 8.7), and being born outside Australia
(OR 2.0, 95% CI 1.1 to 3.7). Table 3 shows the prevalence of
health risk factors according to asthma diagnosis.
The symptom burden of asthma was assessed by the Selim
Index of Chronic Lung Disease (table 4). The distribution of
the frequency of symptoms over the previous 3 months was
similar in the diagnosed and undiagnosed asthma groups,
and both groups were significantly different (p,0.05) from
the no asthma population. Lung function results are shown
in table 5. The group with undiagnosed asthma had
significantly lower mean spirometric values than those with
a self-reported diagnosis of asthma (p,0.01 for all compar-
isons between diagnosed and undiagnosed asthma).
The quality of life in individuals with asthma was more
impaired than in those without asthma. On SF-36 scale
scores, asthma had a severe effect on general health and a
moderate effect on physical functioning, role-physical,
vitality and mental health. Previously undiagnosed asthma
had a significant effect on quality of life in subjects aged
65 years and older and also in men on the physical health
scales (p,0.05), with a severe effect on physical functioning
and a moderate effect on role-physical, general health and
vitality. Table 6 shows the component summary scores
Table 1 Demographic characteristics of the sample









>40 years 48.3 76.8 55.4
,40 years 51.7 23.2 44.6
Sex (% male) 37.3 46.4 50.3
Marital status






Australia 80.1 60.7 69.3
Immigrant 19.9 39.3 30.7
Income
,AUD$40000 51.7 80.4 48.2
.AUD$40000 48.3 19.6 51.8
Social Security
pension
Yes 38.6 51.8 31.0
Employment
Not working 38.6 64.3 35.3
Working currently 61.4 35.7 64.7
Education
High school only 53.0 50.0 47.6
Post high school 47.0 50.0 52.4
Atopy*
Yes 74.6 57.1 57.9
*Atopy = skin test reactions of .2 mm to rye grass, cat, house dust mite,
Alternaria, feather, and cockroach allergens.
p,0.05 for difference diagnosed v undiagnosed asthma.
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according to age and sex. Figure 1 shows standardised scores
for the SF-36 physical and mental component summaries
unadjusted for age and sex and when controlled for age and
sex. This shows a significant effect of asthma in terms of the
burden of illness, as shown by reductions in mean physical
component summary scores in both the diagnosed and
undiagnosed asthma groups. As the differences in scores
are seen in the elderly and in men, it can be seen that, in
population terms, most of the burden for the undiagnosed
asthma group can be accounted for by age and sex, with the
adjusted scores being similar to the group without asthma .
Mental health scores were also affected by asthma. When
adjusted for age and sex, mean mental component summary
scores were significantly lower in the undiagnosed asthma
group than in the population without asthma.
Subjects with asthma used more health services than those
without asthma, particularly general practitioner, hospital
emergency department, and hospital outpatient clinic ser-
vices in South Australia (table 7). Individuals with both
diagnosed and undiagnosed asthma had a significantly
higher mean number of visits to general practitioners and a
higher proportion of frequent (>7) visits over the previous
year than others (p,0.05). The mean number of hospital
outpatient clinic visits was also significantly higher in both
the undiagnosed and diagnosed asthma groups than in the
general population, although this did not reach statistical
significance.
DISCUSSION
Our results indicate that up to one in five people with
probable asthma in this population did not report a
confirmed diagnosis of asthma. Those in the group with
undiagnosed asthma are not merely people with mild lung
function abnormalities without implications for health
status. Their lung function was significantly worse than
those with diagnosed asthma, with implications for increased
mortality.20 The spectrum of symptoms was similar to those
with diagnosed asthma, and was worse than the rest of the
population. In the undiagnosed asthma group much of the
extra burden in terms of quality of life was seen in the elderly
and in men. There is a significant overall quality of life
burden of illness attributable to undiagnosed asthma. It is
clear that undiagnosed asthma represents a substantial
health burden to the community.
To address the health burden first requires the identifica-
tion of individuals with asthma. Those with undiagnosed
asthma tended to be older immigrant men on lower incomes
who were also significantly more likely to suffer from
uncontrolled high blood pressure than the rest of the
population. A similar proportion to the general population
continued to smoke. It is also this group who are suffering
the greatest impairment in quality of life. However, this
group is not invisible to the healthcare system. Subjects with
undiagnosed asthma visited their general practitioner and
hospital outpatient clinics as often as those with diagnosed
asthma. These results suggest that, in part, extra vigilance
from clinicians in all sectors will be required to address the
Table 2 Unadjusted odds ratios (95% CI) for undiagnosed asthma compared with
diagnosed asthma according to demographic variables
Variable Category Odds ratio 95% CI p value
Age ,40 years 1.0
.40 years 3.5 1.7 to 7.7 ,0.001
Sex Female 1.0
Male 1.5 0.8 to 2.7 0.2
Marital status Single 1.0
Married 1.1 0.6 to 2.5 0.8
Birthplace Australia 1.0
Overseas 2.6 1.3 to 5.1 ,0.01
Income >$40 000 1.0
,$40 000 3.8 1.8 to 8.3 ,0.001
Government benefits No pension 1.0
Pension 1.7 1.0 to 3.2 0.05
Employment Employed 1.0
Not working 1.6 0.9 to 3.2 0.1
Education Post school 1.0
High school only 0.9 0.5 to 1.7 0.7
Atopy Yes 0.45 0.24 to 0.87 0.009
Table 3 Health risk factors according to asthma
diagnosis (%)
Diagnosed
asthma (n = 236)
Undiagnosed


















Insufficient/none 50.0 47.3 48.0
Obesity:
BMI .30 kg/m2* 34.7 26.8 27.9
*p,0.05.
Table 4 Percentage of individuals in each category of
lung symptom severity assessed by the Selim Index of
Chronic Lung Disease* according to asthma diagnosis








No asthma (n = 2231) 93.9 5.0 1.1
Total (n = 2523) 91.5 6.7 1.8
*The Selim CLD Index is a 6 item questionnaire with three subscales of
dyspnoea, wheezing, and cough/sputum. The index is scored out of 100,
categorised into mild ( 43), moderate (44–62), and severe (.62) levels
of severity.15
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problems arising from these chronic diseases. In addition,
approaches that use community screening and improved
media publicity may make asthma symptoms and required
action more salient to the general population.
It is possible that clinicians are less likely to consider
asthma to be of significance in older people. In a population
survey of older adults in Bristol, UK, Dow et al found that
2.4% of men had untreated asthma, most of whom had
moderate or severe disease.21 Dickinson et al screened 353
asymptomatic elderly patients aged 60–75 years in a semi-
rural general practice and identified eight (2.3%) with
undiagnosed asthma, but few had significant symptoms.7
Coultas et al reported data from the NHANES III survey of
5743 white adults aged 45 years and older in the US and
found undiagnosed airflow obstruction in 12.0% with only
2.7% reporting doctor diagnosed asthma.9 Dyspnoea was
reported by over 50% of those with an FEV1 ,75% of
predicted.9 Our results suggest that spirometric screening in
primary care should be considered for all smokers and
anyone with chest symptoms. Studies examining the cost
effectiveness of community screening with spirometric tests
are needed.
Socioeconomic differences in asthma diagnostic labelling
have been reported in UK children22 but have not been well
described in adults. Part of this phenomenon may relate to
differences in the presentation with respiratory symptoms to
GPs, which can contribute significantly to the problem of
underdiagnosis of asthma.23 Further work is needed to
determine whether there are socioeconomic or demographic
differences in the presentation of asthma symptoms to GPs.
A number of studies in selected populations have relied on
symptoms to establish the frequency of undiagnosed asthma.
Hahn and Beasley24 found that 3.4% of adults in a general
practice population in Wisconsin had symptoms consistent
with asthma, without a diagnosis having been made. De
Marco et al25 reported that asthma was greatly under-
diagnosed in Italy, and Nish and Schiewtz26 reported that a
diagnosis of asthma had not previously been considered in
30% of young airmen with physiological abnormalities, most
of whom had mild and primarily exercise induced asthma.
Results from the European Community Respiratory Health
Survey show that the prevalence of asthma-like symptoms is
much greater than that of physician diagnosed asthma,27 but
the prevalence of lung function abnormalities consistent with
asthma in the undiagnosed group was not reported. Our
finding that people with undiagnosed asthma have a
spectrum of disease similar to that of diagnosed asthmatics
has not been well described previously.
Our study was limited by the self-reporting of a prior
asthma diagnosis before recruitment. We did not have
information from GP or hospital records to confirm whether
asthma had previously been diagnosed and the individual
was unaware of that fact. However, it can be argued that, if
someone is either unaware or denies that he or she has
asthma, it is not a salient issue; it is unlikely that effective
management will occur, and the potential exists for adverse
health consequences. Self-reports of doctor diagnosed
asthma have a high specificity when validated in relation to
either airway hyperresponsiveness or a clinical diagnosis of
Table 5 Mean (SD) pre-bronchodilator and post-






















FEV1 = forced expiratory volume in 1 second; FVC = forced vital capacity.
*p,0.01 for all comparisons between diagnosed and undiagnosed
asthma.
Table 6 SF-36 physical and mental component summary scores* by age groups according to asthma diagnosis
Physical component summary Mental component summary
Diagnosed Undiagnosed None Diagnosed Undiagnosed None
Age (years)
,40 48.9 (9) 56.1 (1) 52.3 (7) 46.7 (9) 46.6 (8) 47.0 (11)
40–64 43.4 (11) 47.0 (10) 47.9 (9) 46.7 (9) 45.0 (13) 49.2 (10)
>65 37.0 (11) 37.0 (11) 40.9 (10) 50.4 (12) 50.0 (10) 51.8 (10)
Sex
Male 47.4 (11) 42.0 (11) 48.9 (9) 47.2 (11) 48.2 (11) 49.7 (10)
Female 43.7 (11) 47.1 (12) 48.3 (9) 47.5 (9) 46.9 (10) 47.6 (11)
*Population mean score set at 50 with a standard deviation of 10.
Physical
Mental
Diagnosed Undiagnosed No asthma
Diagnosed Undiagnosed No asthma
SF-36 Summary scores

















































Figure 1 Effect of asthma on SF-36 physical component summary (PCS)
and mental component summary (MCS) scores. Scores are shown as z
scores, standardised to the population mean score.
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asthma,28 so we would expect only a small number of those
reporting diagnosed asthma not to have the condition.
It is likely that our prevalence figures for undiagnosed
asthma are an underestimate of the true situation as
reversibility to bronchodilators is a relatively insensitive test
for making a diagnosis.29 30 There are likely to be people who
narrowly fail to attain the criteria for significant reversibility
on the one occasion but who have asthma. However, for the
study to have comparable and robust results, it is necessary to
state the criteria for categorising people with asthma
according to accepted guidelines. Measures of non-specific
airway hyperresponsiveness31 or diurnal variability in peak
flow measurements may identify a further group of people
with undiagnosed asthma. Such measures would also help to
determine if any of those in the undiagnosed asthma group
were poor perceivers of airway obstruction. This phenomenon
has been reported to occur in around 15% of people with
asthma32 and may also account, to some extent, for the fact
that asthma has not been diagnosed in these people.
Despite the inclusion of a relatively large number of
subjects in this study, the absolute numbers with undiag-
nosed asthma were not large. However, the confidence
intervals around this estimate were relatively small, indicat-
ing the robustness of the prevalence estimates. The strength
of this study is that it is a large random sample of people in
this region. The consistency of the pattern of characteristics
of asthma between the diagnosed and undiagnosed asthma
groups suggests that the study is providing an accurate
picture of undiagnosed asthma in the community. The north
west Adelaide region is one of relative social disadvantage
compared with the rest of Adelaide. It is possible that areas
with a different social mix may provide different results.
However, the region remains diverse in terms of all the
sociodemographic characteristics measured. A number of
studies have shown that socioeconomically disadvantaged
groups are at risk for adverse asthma outcomes. It is therefore
reasonable to examine issues that may be contributing to
poorer outcomes in such populations.
The first step in the Australian National Asthma Council
guidelines states the need to establish the diagnosis of
asthma. It is clear that, over a decade after the promulgation
of national guidelines for asthma management, we continue
to fail to achieve this first step for a substantial number of
people. The burden to individuals and to the community from
undiagnosed asthma demands a targeted effort to correct this
problem. A focus on older men may be the first action
needed.
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Table 7 Use of health services over the previous






Mean (SD) 7.1 (6.4) 8.7 (14.9) 4.8 (6.5)
0–2 visits (%) 20.3 35.7 40.7
3–6 visits (%) 41.9 26.8 41.5
>7 visits (%) 37.7 37.5 17.7
Emergency department visits
Mean (SD) 0.36 (0.98) 0.19 (0.69) 0.16 (0.56)
% with >1 visit 20.8 10.0 11.7
Hospital outpatient or specialist clinic visits
Mean (SD) 3.3 (3.6) 3.4 (2.8) 2.8 (3.4)
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